Results 81 to 90 of about 21,521 (247)
Emerging Dissemination of blaCTX‐M‐65 in Bovine E. coli in Spain Associated With IncHI2 Plasmids
MicrobiologyOpen, Volume 15, Issue 3, June 2026.The resistome in ESBL/AmpC‐producing E. coli in livestock was diverse and dominated by plasmid‐borne genes Detection of host‐independent dissemination of AMR determinants mediated by shared plasmid types First report in Spanish cattle of blaCTX‐M‐65 on IncHI2 plasmids, an under‐reported ESBL in Europe Identification of potentially zoonotic clones in ...
Medelin Ocejo +2 more
wiley +1 more source
Prevalence of ESBL-Producing Klebsiella pneumoniae Isolates in Tertiary Care Hospital [PDF]
, 2011 Extended-spectrum β lactamases (ESBLs) continue to be a major challenge in clinical setups world over, conferring resistance to the expanded-spectrum cephalosporins.
Vadde Ramakrishna, Vemula Sarojamma
core +2 more sources
Evaluating the Educational Value of Artificial Intelligence in Pharmacotherapy Education
Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.ABSTRACT Final‐year medical students frequently make prescribing errors, partly because they have had insufficient training in therapeutic reasoning. Students need to understand the underlying rationale behind a drug choice in order to subsequently apply that knowledge critically and independently.
Mariëlle G. Hartjes +4 more
wiley +1 more source
Perbandingan kecepatan pertumbuhan Escherichia coli non ESBL dengan Escherichia coli ESBL
Jurnal Kedokteran Syiah Kuala, 2020 Abstrak. Penelitian ini bertujuan untuk mengidentifikasi perbedaan kecepatan pertumbuhan antara kelompok bakteri Escherichia coli NON ESBL dengan kelompok Escherichia coli ESBL. Jenis dan rancangan penelitian ini adalah penelitian eksperimental. Besar sampel sebanyak 13 isolat bakteri Escherihcia coli. Teknik sampling yang digunakan non random sampling.
Branandito Putra +2 more
openaire +2 more sources
Veterinary Dermatology, Volume 37, Issue 3, Page 345-352, June 2026.Background: Topical antimicrobial therapy is vital for managing pyoderma yet poor compliance can affect treatment outcomes.Hypothesis/objective: To evaluate the antimicrobial activity of a 3% chlorhexidine/ophytrium shampoo at different contact times and the residual activity of a 3% chlorhexidine/ophytrium mousse against meticillin‐susceptible and ...
Matt McHale +4 more
wiley +1 more source
Extended-spectrum beta-lactamase-producing enterobacteriaceae : epidemiology and dynamics of fecal carriage [PDF]
, 2013 ESBL-producing Enterobacteriaceae (EPE) has become a major cause of community acquired urinary tract infection (UTI), and fecal carriage of EPE is emerging worldwide.
Titelman, Emilia
core +1 more source
ChemMedChem, Volume 21, Issue 9, 14 May 2026.Combining enhanced permeability strategies with (2‐pyridyl)methylene substitution in the sulbactam scaffold led to a novel β‐lactamase inhibitor to combat β‐lactamase‐mediated resistance to β‐lactam antibiotics. The studies presented highlight the potential of compound 3 as a next‐generation β‐lactamase inhibitor for combating infections caused by ...
Diana Rodríguez +4 more
wiley +1 more source
Incidência de anemia ferripriva numa população pediátrica detectada na rotina pré-operatória [PDF]
, 2006 O despiste de ferropenia pré operatório numa população pediátrica, pode constituir uma oportunidade para detectar e corrigir estadios deficitários de ferro, susceptíveis de provocar sequelas a médio/longo prazo.
Barbot, José +5 more
core
ESBL-Positive Enterobacteria Isolates in Drinking Water
Emerging Infectious Diseases, 2012 To the Editor: Extended-spectrum β-lactamase (ESBL)–producing members of the family Enterobacteriaceae (enterobacteria) are a worldwide problem (1), but little data are available from central Africa (2). In recent years, ESBL-producing Enterobacteriaceae isolates have shifted from the hospital to the community and the environment (1).
De Boeck, H. +6 more
openaire +4 more sources
Toddlers and terriers: a One Health partnership to combat antimicrobial resistance
Journal of Small Animal Practice, EarlyView.
M. Prodanuk, F. Emdin
wiley +1 more source